Cannabinoids Bacterial Killing In Vitro With and Without Antibiotics
The study will aim to characterize cannabidiol as a potential antibacterial and helper compound in preclinical models of irrigation solution and bone cement release against resistant bacteria in combination or without commonly used antibiotics (vancomycin, tobramycin, bacitracin, gentamicin and cefazolin).
Javad Parvizi, MD, FRCS - Director of Clinical Research at the Rothman Orthopaedic Institute, James Edwards Professor Chair of Orthopaedics at Thomas Jefferson University; and Emanuele Chisari, MD, Post-Doc Research Fellow, Orthopedic Surgery, Rothman Orthopaedic Institute